Andrew co-founded Platinum in 1994 as the Deputy Chief Investment Officer, having worked alongside Kerr for several years at Bankers Trust and perfecting the craft of.. More
Andrew Clifford, Platinum CEO, provides an update.
Molecular biology was Bianca’s first love before she discovered the joys and challenges of investing. After spending some time at Swiss pharmaceuticals company Novartis.. More
Platinum’s founder, Kerr Neilson recently expressed his enthusiasm for the biotech sector. Dr Bianca Ogden, specialist in the field and portfolio manager at Platinum, shares her own excitement for this rapidly growing sector. From gene sequencing, to new drug modalities and molecular...
Dr Bianca Ogden, virologist and manager of the Platinum International Health Care Fund and Julian McCormack, Investment Specialist talk on this podcast with Gemma Dale at NAB.
The coronavirus (COVID-19) is now having an all-encompassing effect on our daily lives. A large number of countries are now in various forms of lockdown, there is little else in our news and markets have fallen a long way as economies suffer.
In response to COVID-19, whilst most of Platinum’s staff are working from home, all of Platinum’s investment, investor services and business functions remain operational.
Following on from our annual roadshows conducted during March, the last remaining adviser roadshows were cancelled and in their place we conducted a webinar for advisers on 19 March.
For investors, please start the video at 6:45 where Andrew Clifford, Platinum’s CIO...